XML 58 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series D Preferred Stock [Member]
Series E Preferred Stock [Member]
Series E-1 Preferred Stock [Member]
Common Stock [Member]
Preferred Stock [Member]
Preferred Stock [Member]
Series D Preferred Stock [Member]
Preferred Stock [Member]
Series E Preferred Stock [Member]
Preferred Stock [Member]
Series E-1 Preferred Stock [Member]
Treasury Stock [Member]
Additional Paid in Capital [Member]
Additional Paid in Capital [Member]
Series D Preferred Stock [Member]
Additional Paid in Capital [Member]
Series E Preferred Stock [Member]
Additional Paid in Capital [Member]
Series E-1 Preferred Stock [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Series E Preferred Stock [Member]
Accumulated Deficit [Member]
Series E-1 Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Series D Warrants [Member]
Series D Warrants [Member]
Common Stock [Member]
Series D Warrants [Member]
Additional Paid in Capital [Member]
Balance at Dec. 31, 2016 $ (1,490)                 $ (51) $ 277,790       $ (279,188)     $ (41)      
Balance (in shares) at Dec. 31, 2016         1         (1)                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Compensation expense for issuance of stock options 50                   50                    
Compensation expense for issuance of restricted stock 79                   79                    
Issuance of common stock and rights for payments made in shares on convertible notes payable 40,121                   40,121                    
Issuance of common stock and rights for payments made in shares on convertible notes payable (in shares)         375                                
Fair value of beneficial conversion feature of convertible note 4,908                   4,908                    
Series B preferred stock dividend (527)                           (527)            
Warrants exercised 19                   19                    
Warrants exercised (in shares)         1                                
Fair value of warrants exercised 2,552                   2,552                    
Net (loss) income (45,117)                           (45,117)            
Foreign currency translation 83                                 83      
Balance at Dec. 31, 2017 678       $ 0         $ (51) 325,519       (324,832)     42      
Balance (in shares) at Dec. 31, 2017         377         (1)                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Compensation expense for issuance of stock options 7                   7                    
Compensation expense for issuance of restricted stock 14                   14                    
Sale of common stock, net of expenses 4,251                   4,251                    
Sale of common stock, net of expenses (in shares)         956                                
Fair value of warrants issued (18,306)                   (18,306)                    
Net (loss) income 7,185                           7,185            
Total comprehensive loss (34)                                 (34)      
Balance at Mar. 31, 2018 (6,205)       $ 0         $ (51) 311,485       (317,647)     8      
Balance (in shares) at Mar. 31, 2018         1,333         (1)                      
Balance at Dec. 31, 2017 678       $ 0         $ (51) 325,519       (324,832)     42      
Balance (in shares) at Dec. 31, 2017         377         (1)                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Net (loss) income (8,353)                                        
Foreign currency translation 63                                        
Balance at Sep. 30, 2018 (4,865)       $ 0         $ (51) 328,266       (333,185)     105      
Balance (in shares) at Sep. 30, 2018         8,138         (1)                      
Balance at Dec. 31, 2017 678       $ 0         $ (51) 325,519       (324,832)     42      
Balance (in shares) at Dec. 31, 2017         377         (1)                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Compensation income related to cancellation of stock options (40)                   (40)                    
Compensation expense for issuance of restricted stock 98                   98                    
Compensation expense for issuance of restricted stock (in shares)         236                                
Sale of common stock, net of expenses 10,916                   10,916                    
Sale of common stock, net of expenses (in shares)         7,624                                
Fair value of warrants issued (18,306)                   (18,306)                    
Cashless exercise of warrants (in shares)         49                                
Issuance of pre-funded warrants 520                   520                    
Exercise of pre-funded Series D Warrants (in shares)         5,250                                
Fair value of warrants issued with convertible notes 5,007                   5,007                    
Fair value of warrants reclassified from liability to equity (4,210)                   (4,210)                    
Fair value of beneficial conversion feature of convertible note 44                   44                    
Issuance of Preferred Stock   $ 1,004                   $ 1,004                  
Issuance of Preferred Stock (in shares)             101                            
Exchange of warrants for common stock (in shares)         1,179                                
Fair value of warrants exchanged for common stock 144                   144                    
Retirement of Treasury Stock                   $ 51 (51)                    
Retirement of Treasury Stock (in shares)                   1                      
Net (loss) income (19,222)                           (19,222)            
Foreign currency translation 8                                 8      
Balance at Dec. 31, 2018 (14,939)       $ 0         $ 0 329,065       (344,054)     50      
Balance (in shares) at Dec. 31, 2018         14,715 101                              
Balance at Mar. 31, 2018 (6,205)       $ 0         $ (51) 311,485       (317,647)     8      
Balance (in shares) at Mar. 31, 2018         1,333         (1)                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Compensation expense for issuance of stock options (47)                   (47)                    
Compensation expense for issuance of restricted stock (95)                   (95)                    
Sale of common stock, net of expenses (41)                   (41)                    
Net (loss) income (6,658)                           (6,658)            
Total comprehensive loss (44)                                 (44)      
Balance at Jun. 30, 2018 (13,090)       $ 0         $ (51) 311,302       (324,305)     (36)      
Balance (in shares) at Jun. 30, 2018         1,333         (1)                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Compensation expense for issuance of restricted stock 116                   116                    
Compensation expense for issuance of restricted stock (in shares)         86                                
Sale of common stock, net of expenses 7,067                   7,067                    
Sale of common stock, net of expenses (in shares)         6,669                                
Cashless exercise of warrants (in shares)         50                                
Issuance of pre-funded warrants 520                   520                    
Fair value of warrants issued with convertible notes 5,007                   5,007                    
Fair value of warrants reclassified from liability to equity (4,210)                   (4,210)                    
Fair value of beneficial conversion feature of convertible note 44                   44                    
Net (loss) income (8,880)                           (8,880)            
Foreign currency translation 105                                        
Total comprehensive loss 141                                 141      
Balance at Sep. 30, 2018 (4,865)       $ 0         $ (51) 328,266       (333,185)     105      
Balance (in shares) at Sep. 30, 2018         8,138         (1)                      
Balance at Dec. 31, 2018 (14,939)       $ 0         $ 0 329,065       (344,054)     50      
Balance (in shares) at Dec. 31, 2018         14,715 101                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Compensation expense for issuance of stock options 54                   54                    
Compensation expense for issuance of restricted stock 4                   4                    
Compensation expense for issuance of restricted stock (in shares)         20                                
Exercise of Pre-Funded Series D Warrants                                         $ (41)
Exercise of pre-funded Series D Warrants (in shares)                                       5,885  
Issuance of Preferred Stock   $ 150                   $ 150                  
Issuance of Preferred Stock (in shares)             15                            
Net (loss) income (7,894)                           (7,894)            
Retirement of Series D Preferred Stock (1,160)                   (1,160)                    
Retirement of Series D Preferred Stock (in Shares)           (116)                              
Total comprehensive loss 7                                 7      
Balance at Mar. 31, 2019 (23,778)       $ 0           328,113       (351,948)     57      
Balance (in shares) at Mar. 31, 2019         20,620                                
Balance at Dec. 31, 2018 $ (14,939)       $ 0         $ 0 329,065       (344,054)     50      
Balance (in shares) at Dec. 31, 2018         14,715 101                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Exchange of warrants for common stock (in shares) 82,521                                        
Net (loss) income $ (21,371)                                        
Foreign currency translation 39                                        
Balance at Sep. 30, 2019 (18,825)       $ 0           364,750       (383,664)     89      
Balance (in shares) at Sep. 30, 2019         26,112 42,082                              
Balance at Mar. 31, 2019 (23,778)       $ 0           328,113       (351,948)     57      
Balance (in shares) at Mar. 31, 2019         20,620                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Compensation expense for issuance of stock options 75                   75                    
Exercise of Pre-Funded Series D Warrants                                     $ (1)   $ (39)
Exercise of pre-funded Series D Warrants (in shares)                                       5,400  
Exchange of warrants for common stock 14                   14                    
Exchange of warrants for common stock (in shares)         92                                
Net (loss) income (5,959)                           (5,959)            
Total comprehensive loss (80)                                 (80)      
Balance at Jun. 30, 2019 (29,729)       $ 0           328,201       (357,907)     (23)      
Balance (in shares) at Jun. 30, 2019         26,112                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Compensation expense for issuance of stock options 70                   70                    
Fair value of warrants issued (20,844)                   (20,844)                    
Issuance of Preferred Stock     $ 29,575 $ 9,510                 $ 42,915 $ 14,408   $ (13,340) $ (4,898)        
Issuance of Preferred Stock (in shares)               32,572 9,510                        
Net (loss) income (7,519)                           (7,519)            
Foreign currency translation 89                                        
Total comprehensive loss 112                                 112      
Balance at Sep. 30, 2019 $ (18,825)       $ 0           $ 364,750       $ (383,664)     $ 89      
Balance (in shares) at Sep. 30, 2019         26,112 42,082